Serum Sclerostin Levels Vary With Season

被引:27
作者
Dawson-Hughes, Bess [1 ,2 ]
Harris, Susan S. [1 ]
Ceglia, Lisa [1 ,2 ]
Palermo, Nancy J. [1 ]
机构
[1] Tufts Univ, Human Nutr Res Ctr Aging, Jean Mayer US Dept Agr, Boston, MA 02111 USA
[2] Tufts Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02111 USA
关键词
BONE TURNOVER; VITAMIN-D; CIRCULATING SCLEROSTIN; POSTMENOPAUSAL WOMEN; PARATHYROID-HORMONE; MARKERS; MECHANISM; PROTEIN; OLDER; MEN;
D O I
10.1210/jc.2013-3148
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Context: To establish the clinical utility of serum sclerostin levels, it is important to know whether there is seasonal variation in the measurements. Objective: This study was done to determine whether serum sclerostin levels vary by season in healthy older men and women. Methods: Serum sclerostin levels were measured in archived serum of 314 healthy men and women aged 65 years and older and examined for seasonal variation. Several factors known to vary by season and previously reported to be associated with serum sclerostin levels, including serum osteocalcin, physical activity, and serum PTH levels, were also measured in these subjects. Sex did not modify the association of season with sclerostin, so the men and women were analyzed together. Results: Serum sclerostin levels varied significantly by season (P < .001, after adjustment for sex). Sclerostin levels in the wintertime were 20% higher than the all-year mean, the levels gradually declined through the spring and summer, and by the fall, they were 20% below the all-year mean. Adjustment for serum osteocalcin, physical activity, and serum PTH did not alter the seasonal means. Seasonal differences in serum osteocalcin, physical activity, and serum PTH were not statistically significant. Conclusions: This study documents marked seasonal variation in serum sclerostin levels. It is important to recognize this source of biological variability when considering the potential clinical utility of sclerostin measurements.
引用
收藏
页码:E149 / E152
页数:4
相关论文
共 17 条
[1]
Serum Sclerostin and Risk of Hip Fracture in Older Caucasian Women [J].
Arasu, Aarthi ;
Cawthon, Peggy M. ;
Lui, Li-Yung ;
Do, Thy P. ;
Arora, Puneet S. ;
Cauley, Jane A. ;
Ensrud, Kristine E. ;
Cummings, Steven R. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (06) :2027-2032
[2]
Physical Activity in Relation to Serum Sclerostin, Insulin-Like Growth Factor-1, and Bone Turnover Markers in Healthy Premenopausal Women: A Cross-Sectional and a Longitudinal Study [J].
Ardawi, Mohammed-Salleh M. ;
Rouzi, Abdulrahim A. ;
Qari, Mohammed H. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (10) :3691-3699
[3]
Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: A novel mechanism for hormonal control of osteoblastogenesis [J].
Bellido, T ;
Ali, AA ;
Gubrij, I ;
Plotkin, LI ;
Fu, Q ;
O'Brien, CA ;
Manolagas, SC ;
Jilka, RL .
ENDOCRINOLOGY, 2005, 146 (11) :4577-4583
[4]
RATES OF BONE LOSS IN POSTMENOPAUSAL WOMEN RANDOMLY ASSIGNED TO ONE OF 2 DOSAGES OF VITAMIN-D [J].
DAWSONHUGHES, B ;
HARRIS, SS ;
KRALL, EA ;
DALLAL, GE ;
FALCONER, G ;
GREEN, CL .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1995, 61 (05) :1140-1145
[5]
Effect of calcium and vitamin D supplementation on bone, density in men and women 65 years of age or older [J].
DawsonHughes, B ;
Harris, SS ;
Krall, EA ;
Dallal, GE .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (10) :670-676
[6]
Effects of Parathyroid Hormone Treatment on Circulating Sclerostin Levels in Postmenopausal Women [J].
Drake, Matthew T. ;
Srinivasan, Bhuma ;
Moedder, Ulrike I. ;
Peterson, James M. ;
McCready, Louise K. ;
Riggs, B. Lawrence ;
Dwyer, Denise ;
Stolina, Marina ;
Kostenuik, Paul ;
Khosla, Sundeep .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (11) :5056-5062
[7]
Association of Circulating Sclerostin With Bone Mineral Mass, Microstructure, and Turnover Biochemical Markers in Healthy Elderly Men and Women [J].
Durosier, Claire ;
van Lierop, Antoon ;
Ferrari, Serge ;
Chevalley, Thierry ;
Papapoulos, Socrates ;
Rizzoli, Rene .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (09) :3873-3883
[8]
RACIAL-DIFFERENCES IN PARATHYROID-HORMONE DYNAMICS [J].
EL-HAJJ FULEIHAN, G ;
GUNDBERG, CM ;
GLEASON, R ;
BROWN, EM ;
STROMSKI, ME ;
GRANT, FD ;
CONLIN, PR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) :1642-1647
[9]
Circulating Levels of Sclerostin Are Increased in Patients with Type 2 Diabetes Mellitus [J].
Garcia-Martin, Antonia ;
Rozas-Moreno, Pedro ;
Reyes-Garcia, Rebeca ;
Morales-Santana, Sonia ;
Garcia-Fontana, Beatriz ;
Garcia-Salcedo, Jose A. ;
Munoz-Torres, Manuel .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (01) :234-241
[10]
Increased Sclerostin Serum Levels Associated with Bone Formation and Resorption Markers in Patients with Immobilization-Induced Bone Loss [J].
Gaudio, Agostino ;
Pennisi, Pietra ;
Bratengeier, Cornelia ;
Torrisi, Venerando ;
Lindner, Brigitte ;
Mangiafico, Roberto A. ;
Pulvirenti, Ivana ;
Hawa, Gerhard ;
Tringali, Giovanni ;
Fiore, Carmelo E. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (05) :2248-2253